Cargando…

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes

Detalles Bibliográficos
Autores principales:	Grummet, Jeremy P., Mottet, Nicolas, Gorin, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Open to Debate For
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385283/ https://www.ncbi.nlm.nih.gov/pubmed/34467236 http://dx.doi.org/10.1016/j.euros.2021.06.009

Ejemplares similares

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—No
por: Olivier, Jonathan, et al.
Publicado: (2021)

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—Referee
por: van den Bergh, Roderick C.N., et al.
Publicado: (2021)

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
por: Grummet, Jeremy, et al.
Publicado: (2020)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023)

Transperineal vs. transrectal biopsy in MRI targeting
por: Grummet, Jeremy, et al.
Publicado: (2017)

Japan should initiate the discussion on voluntary assisted dying legislation now
por: Asai, Atsushi, et al.
Publicado: (2023)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

Are the days of closed pleural biopsy over? Yes
por: Patel, Dharmesh
Publicado: (2015)

Environmental Prevention: Why Do We Need It Now and How to Advance It?
por: Burkhart, Gregor, et al.
Publicado: (2022)

Ether in the developing world: rethinking an abandoned agent
por: Chang, Connie Y., et al.
Publicado: (2015)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
por: Terlizzi, Mario, et al.
Publicado: (2022)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
por: White, Nicholas J.
Publicado: (2019)

How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?
por: Achard, Vérane, et al.
Publicado: (2023)

Stage II Seminoma: Why Chemotherapy Should Remain a Standard
por: Naoun, Natacha, et al.
Publicado: (2023)

Should we maintain baby hatches in our society?
por: Asai, Atsushi, et al.
Publicado: (2013)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against
por: Krishna, Sanjeev
Publicado: (2019)

Diets for patients with chronic kidney disease, should we reconsider?
por: Mitch, William E., et al.
Publicado: (2016)

Should we restrict erythrocyte transfusion in early goal directed protocols?
por: Meybohm, Patrick, et al.
Publicado: (2015)

Adaptive reuse in the healthcare industry: repurposing abandoned buildings to serve medical missions
por: Elrod, James K., et al.
Publicado: (2017)

Open science versus commercialization: a modern research conflict?
por: Caulfield, Timothy, et al.
Publicado: (2012)

An ethics safe harbor for international genomics research?
por: Dove, Edward S, et al.
Publicado: (2013)

Harvard Personal Genome Project: lessons from participatory public research
por: Ball, Madeleine P, et al.
Publicado: (2014)

Disentangling Public Participation In Science and Biomedicine
por: Kelty, Christopher, et al.
Publicado: (2014)

Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis(® )compared to Genentech's Herceptin(®)
por: Baldwin, A Lane, et al.
Publicado: (2013)

Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy
por: Sayres, Lauren C, et al.
Publicado: (2012)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

How To Deal with Renal Cell Carcinoma Tumors >7 cm: The Role of Nephron-sparing Surgery
por: Minervini, Andrea, et al.
Publicado: (2021)

How to Deal with Renal Cell Carcinoma >7 cm: Radical Surgery
por: Grimm, Marc-Oliver, et al.
Publicado: (2021)

Percutaneous Nephrolithotomy: Which Position? Supine Position!
por: Giusti, Guido, et al.
Publicado: (2021)

Percutaneous Nephrolithotomy for Stone Disease: Which Position? Prone Position!
por: Liatsikos, Evangelos, et al.
Publicado: (2021)

The Studer Neobladder: An Established and Reproducible Technique for Intracorporeal Urinary Diversion
por: Lavallée, Etienne, et al.
Publicado: (2021)

Cytoreductive Nephrectomy: Still Necessary in 2021
por: Méjean, Arnaud, et al.
Publicado: (2022)

Which Is the Best Laser for Lithotripsy? Holmium Laser
por: Kim, Hyung Joon, et al.
Publicado: (2022)

Which Is the Best Laser for Lithotripsy? Thulium Fiber Laser
por: Traxer, Olivier, et al.
Publicado: (2022)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Pro
por: Campbell, Steven C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ijjnnnc41rjccdaiusrt4srl0